Direxion Daily S&P Biotech Bull 3X ETF (BMV:LABU)
4,680.00
+160.71 (3.56%)
At close: Sep 21, 2026
BMV:LABU Holdings Information
BMV:LABU is an equity ETF with a total of 177 individual holdings. The top holdings are Spsibi Swap Asset Leg stock at 77.23%, Goldman Finl Sq Trsry Inst 506 at 4.57%, Dreyfus Govt Cash Man Ins at 2.69%, Moderna at 0.89%, and Twist Bioscience at 0.60%.
Total Holdings
177
Top 10 Percentage
85.39%
Asset Class
Equity
ETF Category
Health Care
Assets
9.93B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Spsibi Swap Asset Leg | 21.79% |
| 2 | n/a | Spsibi Swap Asset Leg | 19.85% |
| 3 | n/a | Spsibi Swap Asset Leg | 15.76% |
| 4 | n/a | Spsibi Swap Asset Leg | 13.36% |
| 5 | n/a | Goldman Finl Sq Trsry Inst 506 | 4.57% |
| 6 | n/a | Spsibi Swap Asset Leg | 3.49% |
| 7 | n/a | Dreyfus Govt Cash Man Ins | 2.69% |
| 8 | n/a | Spsibi Swap Asset Leg | 1.80% |
| 9 | n/a | Spsibi Swap Asset Leg | 1.18% |
| 10 | MRNA | Moderna, Inc. | 0.89% |
| 11 | TWST | Twist Bioscience Corporation | 0.60% |
| 12 | n/a | Cash | 0.58% |
| 13 | NTRA | Natera, Inc. | 0.44% |
| 14 | HALO | Halozyme Therapeutics, Inc. | 0.40% |
| 15 | ORKA | Oruka Therapeutics, Inc. | 0.40% |
| 16 | KYMR | Kymera Therapeutics, Inc. | 0.39% |
| 17 | IOVA | Iovance Biotherapeutics, Inc. | 0.38% |
| 18 | ROIV | Roivant Sciences Ltd. | 0.37% |
| 19 | TVTX | Travere Therapeutics, Inc. | 0.36% |
| 20 | CGON | CG Oncology, Inc. | 0.36% |
| 21 | RVMD | Revolution Medicines, Inc. | 0.35% |
| 22 | PTGX | Protagonist Therapeutics, Inc. | 0.35% |
| 23 | INSM | Insmed Incorporated | 0.35% |
| 24 | PCVX | Vaxcyte, Inc. | 0.35% |
| 25 | SMMT | Summit Therapeutics Inc. | 0.34% |
As of Sep 17, 2026